Neurochemical Research

, Volume 23, Issue 6, pp 919–922 | Cite as

Elevated Nerve Growth Factor Levels in the Synovial Fluid of Patients with Inflammatory Joint Disease

  • Dale A. Halliday
  • Christian Zettler
  • Robert A. Rush
  • Raffaele Scicchitano
  • Julian D. McNeil
Article

Abstract

A novel pH shock extraction procedure was used to measure nerve growth factor (NGF) levels in both normal and inflamed synovial fluids using a sensitive and specific two-site enzyme linked immunosorbant assay. To date no data is available on NGF levels in normal synovial fluids. Synovial fluids were taken from 5 normal volunteers, 12 patients with rheumatoid arthritis and 10 patients with other inflammatory arthropathies. The mean ± SEM NGF concentration in normal synovial fluids was 95 ± 33.2 pg/ml (range 39.1–143.1 pg/ml), whereas the mean NGF concentration in the synovial fluids taken from patients with rheumatoid arthritis was 532.5 ± 123.8 pg/ml (range 152–1686 pg/ml). The mean NGF concentration in patients with other inflammatory arthropathies was also raised (430.6 ± 90 pg/ml; range 89–1071 pg/ml). The NGF concentrations were significantly higher in the synovial fluids from both inflamed groups (ANOVA p < 0.05) compared to normals. Raised levels of NGF in synovial fluid may contribute directly to joint inflammation via activation of inflammatory cells.

Nerve growth factor inflammation arthritis synovial fluid pain 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Barde, Y.-A. 1989. Trophic factors and neuronal survival. Neuron. 2:1525–34.PubMedGoogle Scholar
  2. 2.
    Otten, U., Scully, J. L., Ehrhard, P. B., and Gadient, R. A. 1994. Neurotrophins: signals between the nervous and immune systems. Prog. Brain Res. 103:293–305.PubMedGoogle Scholar
  3. 3.
    Lindholm, D., Heumann, T., Meyer, M., and Thoenen, H. 1987. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of sciatic nerve. Nature 330:658–659.PubMedGoogle Scholar
  4. 4.
    Gillardon, F., Eschenfelder C., Rush, R. A., and Zimmerman, M. 1995. Increase in neuronal Jun immunoreactivity and epidermal NGF levels following UV exposure of rat skin. Neuroreport 6:1322–1324.PubMedGoogle Scholar
  5. 5.
    Steiner, P., Pfeilschifter, J., Boeckh, C., Radeke, H., and Otten, U. 1991. Interleukin-1β and tumour necrosis-α synergistically stimulate nerve growth factor synthesis in rat mesangial cells. Am. J. Physiol. F792–F798.Google Scholar
  6. 6.
    Mazurek, N., Weskamp, G., Erne, E., and Otten, U. 1986. Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS. Lett. 315–320.Google Scholar
  7. 7.
    Bischoff-Laudiero, S. C., and Dalhinden, C. A. 1992. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 79:2662–2669.PubMedGoogle Scholar
  8. 8.
    Laudiero, L. B., Aloe, L., Levi-Montalcini, R., Buttinelli, C., Schilter, D., Gillesson, S., and Otten, U. 1992. Multiple sclerosis patients express increased levels of β-nerve growth factor in cerebrospinal fluid. Neurosci. Lett. 147:9–12.PubMedGoogle Scholar
  9. 9.
    Dicou, E., Hurez, D., and Nerriere, V. 1993. Natural autoantibodies against the nerve growth factor in autoimmune diseases. J. Neuroimmunol. 47:159–168.PubMedGoogle Scholar
  10. 10.
    Aloe, L., Tuveri, M. A., Carcassi, U., and Levi-Montalcini, R. 1992. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum. 35:351–355.PubMedGoogle Scholar
  11. 11.
    Zettler, C., Bridges, D. C., McL., Zhou, X.-F., and Rush, R. A. 1996. Detection of increased tissue concentrations of nerve growth factor with an improved extraction procedure. J. Neurosci. Res. 46:581–594.PubMedGoogle Scholar
  12. 12.
    Liu, D. T., Reid, M. T., Bridges, D. C., McL., and Rush, R. A. 1996. Denervation but not decentralization, reduces nerve growth factor content of the mesenteric artery. J. Neurochem. 66:2295–2299.PubMedGoogle Scholar
  13. 13.
    Dicou, E., Perrot, S., Menkes, C. J., Masson, C., and Nerriere, V. 1996. Nerve growth factor (NGF) autoantibodies and NGF in the synovial fluid: Implications in spondylarthropathies. Autoimmunity 24:1–9.Google Scholar
  14. 14.
    Feldman, M., Brennan, F. M., and Maini, R. N. 1990. Role of cytokines in autoimmune disease. Pages 185–194, in: Aggarwal, B., and Puri, R. (Eds.), Human cytokines: their role in disease and therapy, Blackwell Science, Cambridge, MA.Google Scholar
  15. 15.
    Leon, A., Buriani, A., Dal Toso, R., Fabris, M., Romanells, S., and Aloe, L. 1994. Mast cells synthesise, store and release nerve growth factor. Proc. Natl. Acad. Sci. USA. 91:3739–3743.PubMedGoogle Scholar
  16. 16.
    Aloe, L., Probert, L., Kollias, G., Braci-Laudiero, L., Spillantini, M. G., and Levi-Montalcini, R. 1993. The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growth factor. Growth Factors 9:149–155.PubMedGoogle Scholar
  17. 17.
    Lewin, G. R., Ritter, A. M., and Mendell, L. M. 1993. Nerve growth factor induced hyperalgesia in the neonatal and adult rat. J. Neurosci. 13:2136–2148.PubMedGoogle Scholar
  18. 18.
    Petty, B. G., Comblath, D. R., Adornato, B. T., Chaudhry, V., Flexner, C., and Waschsman, M. 1994. The effect of systematically administered recombinant human nerve growth factor in healthy human subjects. Ann. Neurol. 36:244–246.PubMedGoogle Scholar
  19. 19.
    McMahon, S. B., Bennett, D. H., Preistly, J. V., and Shelton, D. L. 1995. The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nature Medicine 1:774–780.CrossRefPubMedGoogle Scholar
  20. 20.
    Gronblad, M., Kottinen, Y. T., Korkala, O., Liesi, P., Hukkanen, M., and Polak, J. M. 1988. Neuropeptides in synovium of patients with rheumatoid arthritis and osteoarthritis. J. Rheum. 15:1807–1811.PubMedGoogle Scholar
  21. 21.
    Vedder, H., Affolter, H.-U., and Otten, U. 1993. Nerve growth factor (NGF) regulates tachykinin gene expression and biosynthesis in rat sensory neurons during early postnatal development. Neuropeptides 24:351–357.CrossRefPubMedGoogle Scholar
  22. 22.
    Lotz, M., Carson, D. A., and Vaughan, J. H. 1987. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 235:893–895.PubMedGoogle Scholar
  23. 23.
    Goedert, M., Stoeckel, K., and Otten, U. 1987. Biological importance of the retrograde axonal transport of nerve growth factor in sensory neurons. Proc. Natl. Acad. Sci. USA. 78:5895–5898.Google Scholar
  24. 24.
    Halliday, D. A., McNeil, J. D., Betts, W. H., and Scicchitano, R. 1993. The substance P fragment SP[7–11] increases prostaglandin E2, intracellular Ca2+ and collagenase production in bovine articular chondrocytes. Biochem. J. 292:57–62.PubMedGoogle Scholar
  25. 25.
    Levine, J. D., Goetzl, E. J., and Basbaum, A. I. 1987. Contribution of the nervous system to the pathophysiology of rheumatoid arthritis and other poliarthrides. Rheum. Dis. Clin. North Am. 2:369–383.Google Scholar
  26. 26.
    Aloe, L., Tuveri, M. A., and Levi-Montalcini, R. 1992. Studies on carrageenan-induced arthritis in adult rats: Presence of nerve growth factor and role of sympathetic innervation. Rheumatol. Int. 12:213–21.CrossRefPubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1998

Authors and Affiliations

  • Dale A. Halliday
    • 1
  • Christian Zettler
    • 2
  • Robert A. Rush
    • 2
  • Raffaele Scicchitano
    • 3
  • Julian D. McNeil
    • 4
  1. 1.Department of Immunopathology Women's and Children's HospitalAdelaideSouth Australia
  2. 2.Department of Physiology and Centre for NeuroscienceFlinders University of South AustraliaAdelaideSouth Australia
  3. 3.Department of Thoracic MedicineRoyal Adelaide Hospital, North TceAdelaideSouth Australia
  4. 4.Department of Medicine, Modbury HospitalThe University of Adelaide, North TceAdelaideSouth Australia

Personalised recommendations